Retroviral Infection Dynamics in Maine\u27s Wild Turkeys

Widespread wild turkey reintroductions in the late 1900s have led to increases in population density and geographic distribution across North America. This rapid population expansion has put them into proximity with closely-related wild and domestic avian species, increasing the risks of pathogen transmission. Lymphoproliferative disease virus (LPDV) is an avian oncogenic retrovirus detected in wild turkeys in 2009, and previously known to infect domestic turkeys. Following its initial detection, surveys reported variable LPDV prevalence across eastern North America with most wild turkeys being asymptomatic, however diagnostic cases revealed 10% mortality of LPDV-infected individuals. Given its recent detection, little is known about LPDV ecology, transmission or evolution in wild turkeys. We sought to evaluate (1) an alternative detection method for surveillance, (2) individual risk factors, (3) fitness effects, and (4) the genetic diversity and evolutionary history of LPDV in Maine’s wild turkeys. From 2017–2020, we collected tissues and associated data from 72 hunter-harvested and 627 live-captured wild turkeys, and attached radiotransmitters to a subset of live-captured females to monitor survival and reproduction. We used PCR to estimate the infection prevalence of LPDV (59%) and reticuloendotheliosis virus (REV; 16%), another oncogenic retrovirus. In a sample subset, we used plate agglutination to determine the prevalence of exposure to the bacteria, Mycoplasma gallisepticum (74%) and Salmonella pullorum (3.4%). We found cloacal swabs are a reliable LPDV detection method for live-captured wild turkeys. Sex, age, and season were significant predictors of LPDV infection, with females, adults, and individuals sampled in spring having a higher infection risk. Furthermore, we found both LPDV and REV infection negatively affected individual fitness by reducing clutch size and weekly hen survival rate, respectively. Finally, LPDV in Maine is characterized by high diversity and weak spatial genetic structure, which we hypothesize may be driven by high mutation rates, intrahost pathogen dynamics, and/or the history of human-induced and natural wild turkey movement across the state. Overall, this study provides valuable insights into LPDV infection, transmission, and evolution in wild turkeys, data which will aid in future disease monitoring and risk assessments to evaluate effects of infection on wild turkey population dynamics

Animals, Affect and Annihilation: Campaigns against Canids in Postwar Canada

Abstract This essay suggests that culling campaigns against canids in postwar Canada have striking affective dimensions. Drawing on examples of canid management in the 1950s and 60s from Nunavik, Alberta, and Ontario, we contend that the killing of supposedly rabid dogs and wild canids was predominantly about affective excess and emotional management. The wildness of these animals was perceived to lead to excessive nonhuman affectivity, which was seemingly exacerbated by rabies. Human encounters with these animals were characterised by excessive affective responses, a result of long-standing fears of rabies, anxieties about northernness and assertions of ‘civilisation’ in the context of settler colonialism. This fear was then channelled into round ups and killings of canids. The killing was what Monique Scheer calls an ‘emotional practice’ designed to soothe anxieties, to cleanse and to civilise. Drawing on archival and other documentary sources, we aim to show the value in exploring more fully the intersections between affect and animal histories.</jats:p

Association of Rideshare-Based Transportation Services and Missed Primary Care Appointments: A Clinical Trial

In a pragmatic trial, offering complimentary ridesharing services broadly to Medicaid patients did not reduce rates of missed primary care appointments. The uptake of free rides was low, and rates of missed appointments remained unchanged at 36%. Efforts to reduce missed appointments due to transportation barriers may require more targeted approaches

Capture and Recycle of Industrial CO\u3csub\u3e2\u3c/sub\u3e Emissions Using Mircoalgae

A novel cyclic flow photobioreactor (PBR) for the capture and recycle of CO2 using microalgae was designed and deployed at a coal-fired power plant (Duke Energy’s East Bend Station). The PBR was operated continuously during the period May–September 2015, during which algae productivity of typically 0.1–0.2 g/(L day) was obtained. Maximum CO2 capture efficiency was achieved during peak sunlight hours, the largest recorded CO2 emission reduction corresponding to a value of 81 % (using a sparge time of 5 s/min). On average, CO2 capture efficiency during daylight hours was 44 %. The PBR at East Bend Station also served as a secondary scrubber for NOx and SOx, removing on average 41.5 % of the NOx and 100 % of the SOx from the flue gas. The effect of solar availability and self-shading on a rudimentary digital model of the cyclic flow PBR was examined using Autodesk Ecotect Analysis software. Initial results suggest that this is a promising tool for the optimization of PBR layout with respect to the utilization of available solar radiation

Capture and Recycle of Industrial CO\u3csub\u3e2\u3c/sub\u3e Emissions Using Mircoalgae

A novel cyclic flow photobioreactor (PBR) for the capture and recycle of CO2 using microalgae was designed and deployed at a coal-fired power plant (Duke Energy’s East Bend Station). The PBR was operated continuously during the period May–September 2015, during which algae productivity of typically 0.1–0.2 g/(L day) was obtained. Maximum CO2 capture efficiency was achieved during peak sunlight hours, the largest recorded CO2 emission reduction corresponding to a value of 81 % (using a sparge time of 5 s/min). On average, CO2 capture efficiency during daylight hours was 44 %. The PBR at East Bend Station also served as a secondary scrubber for NOx and SOx, removing on average 41.5 % of the NOx and 100 % of the SOx from the flue gas. The effect of solar availability and self-shading on a rudimentary digital model of the cyclic flow PBR was examined using Autodesk Ecotect Analysis software. Initial results suggest that this is a promising tool for the optimization of PBR layout with respect to the utilization of available solar radiation

Human papillomavirus (HPV69/HPV73) coinfection associated with simultaneous squamous cell carcinoma of the anus and presumed lung metastasis

Background: Human papillomaviruses (HPVs) have been linked to a variety of human cancers. As the landscape of HPV-related neoplasia continues to expand, uncommon and rare HPV genotypes have also started to emerge. Host-virus interplay is recognized as a key driver in HPV carcinogenesis, with host immune status, virus genetic variants and coinfection highly influencing the dynamics of malignant transformation. Immunosuppression and tissue tropism are also known to influence HPV pathogenesis. Methods: Herein, we present a case of a patient who, in the setting of HIV positivity, developed anal squamous cell carcinoma associated with HPV69 and later developed squamous cell carcinoma in the lungs, clinically presumed to be metastatic disease, associated with HPV73. Consensus PCR screening for HPV was performed by real-time PCR amplification of the L1 gene region, amplification of the E6 regions with High-Resolution Melting Curve Analysis followed by Sanger sequencing confirmation and phylogenetic analysis. Results: Sanger sequencing of the consensus PCR amplification product determined that the anal tissue sample was positive for HPV 69, and the lung tissue sample was positive for HPV 73. Conclusions: This case underscores the importance of recognizing the emerging role of these rare 'possibly carcinogenic' HPV types in human carcinogenesis. © 2020 by the authors. Licensee MDPI, Basel, Switzerland

Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians

Hematopoietic cell transplantation can cure many high-risk diseases but is associated with complexity, cost, and risk. Several areas in transplantation practice were identified in the 2014 Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium (BMT CTN SOSS) as high priorities for further study. We developed a survey for hematopoietic cell transplantation clinicians to identify current practices in BMT CTN SOSS priority areas and to understand, more generally, the variation in approach to transplantation and estimation of transplantation benefit in current medical practice. Of 1439 transplantation clinicians surveyed, 305 responded (20% response rate). Clinicians were well represented by age, experience, geography, and size of practice. We found that several techniques identified in the BMT CTN SOSS, such as maintenance therapy for acute myeloid leukemia or myelodysplastic syndromes after allogeneic transplantation, were already being utilized in practice on and off study, with higher rates of use in higher-volume centers. There was significant variation among clinicians in use of transplantation technologies and approaches to common transplantation scenarios. Appraisals of risks and benefits of transplantation appeared to converge upon similar estimates despite the presentation of different hypothetical scenarios. These results suggest overall equipoise in several BMT CTN SOSS high-priority areas and support the need for better data to inform clinical practice

Intraperitoneal Nanotherapy for Metastatic Ovarian Cancer Based on siRNA-Mediated Suppression of DJ-1 Protein Combined with a Low Dose of Cisplatin

Herein, we report an efficient combinatorial therapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. DJ-1 protein modulates, either directly or indirectly, different oncogenic pathways that support and promote survival, growth, and invasion of ovarian cancer cells. To evaluate the potential of this novel therapy, we have engineered a cancer-targeted nanoplatform and validated that DJ-1 siRNA delivered by this nanoplatform after intraperitoneal injection efficiently downregulates the DJ-1 protein in metastatic ovarian cancer tumors and ascites. In vivo experiments revealed that DJ-1 siRNA monotherapy outperformed cisplatin alone by inhibiting tumor growth and increasing survival of mice with metastatic ovarian cancer. Finally, three cycles of siRNA-mediated DJ-1 therapy in combination with a low dose of cisplatin completely eradicated ovarian cancer tumors from the mice, and there was no cancer recurrence detected for the duration of the study, which lasted 35 weeks

Enhanced efficacy and increased long-term toxicity of CNS-directed, AAV-based combination therapy for Krabbe disease

Infantile globoid cell leukodystrophy (GLD, Krabbe disease) is a demyelinating disease caused by the deficiency of the lysosomal enzyme galactosylceramidase (GALC) and the progressive accumulation of the toxic metabolite psychosine. We showed previously that central nervous system (CNS)-directed, adeno-associated virus (AAV)2/5-mediated gene therapy synergized with bone marrow transplantation and substrate reduction therapy (SRT) to greatly increase therapeutic efficacy in the murine model of Krabbe disease (Twitcher). However, motor deficits remained largely refractory to treatment. In the current study, we replaced AAV2/5 with an AAV2/9 vector. This single change significantly improved several endpoints primarily associated with motor function. However, nearly all (14/16) of the combination-treated Twitcher mice and all (19/19) of the combination-treated wild-type mice developed hepatocellular carcinoma (HCC). 10 out of 10 tumors analyzed had AAV integrations within the Rian locus. Several animals had additional integrations within or near genes that regulate cell growth or death, are known or potential tumor suppressors, or are associated with poor prognosis in human HCC. Finally, the substrate reduction drug L-cycloserine significantly decreased the level of the pro-apoptotic ceramide 18:0. These data demonstrate the value of AAV-based combination therapy for Krabbe disease. However, they also suggest that other therapies or co-morbidities must be taken into account before AAV-mediated gene therapy is considered for human therapeutic trials